Press Releases
Public Relations: Andrew Noble
DNAnexus and Galatea Bio Launch Collaboration to Enhance Precision Medicine with Advanced Genetic Tools for Underserved Populations
Under the new agreement, Galatea Bio will use DNAnexus' Precision Health Data Cloud to increase the availability and speed of the analysis of its diverse non-European datasets. Importantly, this collaboration will allow DNAnexus' extensive network of more than 48,000 users across 48 countries to potentially leverage Galatea’s advanced local ancestry and ancestry-adjusted PRS (polygenic risk score) algorithms.
UK Biobank and DNAnexus Collaboration Earns Bio-IT World 2024 Innovative Best Practices Global Impact Award for 500,000 Whole Genomes Data Release
DNAnexus and Oracle Collaborate to Advance Precision Health
We are excited to announce we have teamed up with Oracle to advance precision health by connecting our respective ecosystems. The DNAnexus platform will be seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. In addition, customers will be able to use OCI integration services for their healthcare applications. DNAnexus customers will be able to leverage Oracle’s expertise in accelerating AI pipelines and its industry partnerships to bring global customers even faster genomic analysis and better AI models.
DNAnexus Adds NVIDIA NIM and CUDA-X Microservices to Precision Health Data Cloud to Accelerate Drug Discovery and Improve Patient Care
New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU
DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit
Co-founder of Ovation to share how researchers are using DNAnexus’ Precision Health Data Cloud to streamline analysis, identify optimal therapeutic targets, and advance drug discovery.
News
World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone
In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants. This is set to drive the discovery of new diagnostics, treatments and cures and, uniquely, is available to approved researchers worldwide, via a protected database containing only de-identified data (e.g. name, address, date of birth, name of GP and more stripped out).
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies.